In vivo studies have demonstrated IGF-1 deficiency results in increased oxidative stress, inflammation, neuronal cell death and cognitive deficits that can be improved by exogenous IGF-1 [19, 20]. The gene discussed is IGF1; the disease is Cognitive impairment.